Devices › Instrument, vitreous aspiration and cutting, ac-powered
Device brand name · Ophthalmic microsurgical unit
Storz Premiere Ophthalmic Microsurgical Unit: medical device reports filed with FDA
370 reports name it, 1996–2000. Manufacturer given most often on reports: Storz Instrument. Product code HQE.
- 370
- device reports naming the brand
- 0% of all MAUDE reports · about 12 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 95.4%
- classified as malfunction
- 56.3% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 370 reports that name the brand "Storz Premiere Ophthalmic Microsurgical Unit" (ophthalmic microsurgical unit), received between September 1996 and October 2000; the manufacturer given most often on reports is Storz Instrument. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (95.4%) and injury (4.1%); across all instrument, vitreous aspiration and cutting, ac-powered reports (product code HQE) death is recorded in 0% and malfunction in 56.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are device issue (59.7%), replace (19.7%) and failure, intermittent (14.6%). The patient problems coded most often are eye injury, surgical procedure and membrane, breakage of. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Storz Premiere Ophthalmic Microsurgical Unit was received in the five years to August 2026; the latest was received in October 2000.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 5,964 reports carrying product code HQE. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Device issuea problem with the device | 221 | 59.7% | 10.2% |
| Replace | 73 | 19.7% | 9.7% |
| Failure, intermittent | 54 | 14.6% | 1.7% |
| Aspiration, incomplete | 30 | 8.1% | 1.9% |
| Loss of powerthe device lost power | 30 | 8.1% | 2.4% |
| Malfunction | 29 | 7.8% | 1.7% |
| Failure to calibrate | 20 | 5.4% | 0.4% |
| Defective component | 14 | 3.8% | 1.3% |
| Sticking | 10 | 2.7% | 1.2% |
| Other (for use when an appropriate device code cannot be identified) | 6 | 1.6% | 4.5% |
| Reflux within device | 5 | 1.4% | 0.1% |
| Suction problem | 5 | 1.4% | 2.2% |
| Cautery | 4 | 1.1% | 0.1% |
| Power conditioning problem | 4 | 1.1% | 0.4% |
| Self-activation or keying | 4 | 1.1% | 0.3% |
| Aspiration, excessive | 3 | 0.8% | 0.2% |
| Device remains activated | 3 | 0.8% | 0.3% |
| System fails to activate | 3 | 0.8% | 0.1% |
| Valve(s), sticking | 3 | 0.8% | 0.1% |
| Calibration error | 2 | 0.5% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Eye injury | 20 | 5.4% |
| Surgical procedure | 4 | 1.1% |
| Membrane, breakage of | 2 | 0.5% |
| Infective keratitis | 1 | 0.3% |
| Retinal injury | 1 | 0.3% |
| Retinal tear | 1 | 0.3% |
| Surgery, prolonged | 1 | 0.3% |
| Surgical procedure aborted/stopped | 1 | 0.3% |
| Therapy/non-surgical treatment, additional | 1 | 0.3% |
| Treatment with medication(s) | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Storz Premiere Ophthalmic Microsurgical Unit | Product code HQE | All MAUDE reports |
|---|---|---|---|
| Reports | 370 | 5,964 | 26,136,888 |
| Share of that pool | — | 6.2% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 4.1% | 42.3% | 36.2% |
| Classified as malfunction | 95.4% | 56.3% | 62.3% |
| Filed by the manufacturer | 100% | 95.2% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code HQE
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Series Twenty Thousand Legacy | 2,573 | 0 | 0% |
| Laser Probes | 512 | 27 | 0% |
| HyperVit Vitrectomy Probe | 336 | 221 | 0% |
| Accurus 800cs | 1,457 | 0 | 0% |
| Backflush Handle DSP | 233 | 43 | 0% |
| Accurus 600ds | 217 | 0 | 0% |
| Accurus 400vs | 525 | 0 | 0% |
| Infiniti Vision System | 5,259 | 0 | 0% |
| Alcon | 180 | 2 | 0% |
| Millennium Microsurgical System | 152 | 0 | 0% |
| Series 20000 Legacy | 370 | 0 | 0% |
| Viscoat | 220 | 0 | 0.5% |
| Infiniti Vision System Ozil | 3,530 | 0 | 0% |
| M Series | 27,112 | 4 | 2.3% |
| Custom Pak | 1,262 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Storz Premiere Ophthalmic Microsurgical Unit reports
How many FDA reports name Storz Premiere Ophthalmic Microsurgical Unit?
370 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (95.4%) and injury (4.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
device issue (59.7%), replace (19.7%), failure, intermittent (14.6%), aspiration, incomplete (8.1%) and loss of power (8.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Storz Premiere Ophthalmic Microsurgical Unit was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.